Lift population glycemic control and close quality gaps, HEDIS, MIPS, and Stars, cutting complications and avoidable admissions across your members.
Poorly controlled diabetes drives the most expensive claims you carry, admissions, ED visits, and complications, and it drags your quality scores down with it.
Endobits gives you continuous visibility across your at-risk members, and closes the gaps that cost you most.
Continuous glucose visibility across your at-risk members, not just at claims time.
Pulls down your >9% A1c population and lifts HEDIS, MIPS, and Star measures.
Catches deterioration early, before it becomes an admission.
Fewer complications and admissions across the population.
Model flags a high probability of a severe hypoglycemia admission within 30 days. Care management is auto-notified to trigger outreach and a medication review, projected to avoid an estimated $18,000 inpatient episode.
Glycemic trend is deteriorating and this member is on track to cross the >9% HEDIS threshold. Endobits prioritizes them for a care-management touch and titration review, closing a quality gap before it lands and heads off downstream complication cost.
Rising glycemic variability puts this member on a costly trajectory. Outreach is already underway, a nurse touchpoint and adherence check are in progress to pull the member back to target and keep them out of the high-cost tier.
This member is well-controlled and low-cost. No intervention is needed, Endobits keeps them in continuous monitoring so any drift is caught early, freeing your care-management capacity for the members who move the numbers.
Illustrative. Reviewing a single member's CGM profile takes a trained reviewer roughly 30–45 minutes; Endobits stratifies an entire population in real time.
Stand up Endobits for your plan in days, no new infrastructure to deploy.
Securely connect claims and device feeds. One integration, no member disruption.
Endobits surfaces the members heading toward costly complications, before they land.
We predict, prioritize, and prevent. Your care-management team reviews the panel and approves the outreach.
Figures are illustrative and drawn from published sources; actual population dynamics vary by plan. Endobits is clinical decision-support software, not a guarantee of savings or quality outcomes.
Tell us your covered lives and prevalence. See the diabetic population at stake and the avoidable cost you could address.
Built on a trusted ecosystem